Progenity (PROG) Stock: Why The Price Jumped Today

By Amit Chowdhry ● Nov 4, 2021
  • The stock price of Progenity Inc (NASDAQ: PROG) increased by over 19% during intraday trading today. This is why it happened.

The stock price of Progenity Inc (NASDAQ: PROG) increased by over 19% during intraday trading today. Investors are responding positively to Progenity announcing the appointment of Jill Howe to its board of directors effective November 3, 2021. Howe was also appointed chairperson of the Audit Committee and member of the Nominating and Corporate Governance Committee.

Howe is the Chief Financial Officer for DTxPharma and serves on the Board of Directors for Codagenix and the MUSC Foundation for Research Development. And she has over 20 years of experience in the biotechnology sector in operational and financial strategy, treasury, global infrastructure, and compliance management. 

Before joining DTx, Howe served as Treasurer and Vice President of Finance for Gossamer Bio, a clinical-stage biopharmaceutical company, where she was the internal project lead for the company’s initial public offering, follow-on, and debt offerings, and oversaw finance for 18 subsidiaries across the U.S. and Ireland. She had previously held Controller and Director of Finance roles at Amplyx Pharmaceuticals, Receptos, and Somaxon Pharmaceuticals. Howe received a Bachelor of Science in Accountancy from San Diego State University.


“As Progenity continues to execute its strategic transformation, we are adding key leadership capabilities that will allow us to continue accelerating our efforts to develop the drug discovery and delivery systems of the future. Jill brings proven financial leadership and extensive pharmaceutical industry experience, which will be invaluable in her role as chair of the Audit Committee for Progenity.”

— Eric d’Esparbes, interim CEO of Progenity

“It’s an exciting time for Progenity as there is incredible depth and potential in the R&D pipeline. I look forward to working with the team to ensure the company’s potential is valued.”

— Jill Howe

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.